Fritextsökning
Innehållstyper
-
Swedish nanotech crosses the Atlantic
Genovis signs distribution agreement Finnzymes in US.
-
”Sverige klarar tillverkningen”
I Matfors bygger Cobra Biologics två unika tillverkningssviter för storskalig GMP-tillverkning av ATMP-produkter. Kontraktstillverkaren rustar för att möta den ...
-
Smuggling för miljarder
Läkemedel för 200 miljarder dollar - så stort är värdet på förfalskningsmarknaden visar en ny undersökning.
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
Fat cells' reaction differs with body weight
The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...
-
Ansöker om godkännande i USA
Scandidos ansöker om snabbgodkännande för två produkter av FDA.
-
Akademisk forskning får 843 miljoner
Nu är Vetenskapsrådets stora bidragsutlysning klar. Var femte ansökan beviljades inom medicin och hälsa.
-
Kartlägger mikrobiomet
I samarbete med Ferring ska forskare vid Karolinska Institutet utforska de mikroorganismer som lever i och på kroppen.
-
Harmony prevents dementia
People who are active, outgoing and relaxed may be less likely to develop dementia, according to a new study from Karolinska Institutet.
-
New Nordic nutrition collaboration
Scandinavian Clinical Nutrition has recently signed a unique Nordic distribution agreement.
-
Novo Nordisk bygger nytt
Danska läkemedelsjätten miljonsatsar på ny FoU-anläggning
-
LabDays: ”Det är en ganska mörk bild jag pekar ut nu”
Utmaningar inom global hälsa, analys av torkat blod, gensekvensering, manlig infertilitet och detektion av droger i saliv var några av de ämnen som avhandlades ...
-
Positivt från RLS
Visar starka resultat i ny studie på diabetesfotsår.
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
Martin Bergö: "The Idea is the Thing"
Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...
-
Pfizer buys Swiss vaccines
Pfizer executes commercial license agreements for novel human vaccines based on the Swiss company Cytos Biotechnology's Immunodrug technology.
-
Finnish Innovation Fund gets new leader
The Supervisory Board of the Finnish Innovation Fund Sitra has appointed members of the Board, including a new president.
-
Norwegian entrance in EU technology network
The Norwegian University of Science and Technology joins the European Science Business Network of prominent European research institutions.
-
Immunicum-teknik i lyckad preklinisk studie
Resultaten publiceras i en vetenskaplig tidskrift.
-
Skär ner på personalen
En omfördelning av resurserna leder till nedskärningar i utvecklingsverksamheten på ScandiDos.
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
-
Danish focus on bio chemicals
The Danish company Genencor and the German company BRAIN establish a research collaboration for the production of biobased chemicals from renewable feedstock.
BREAKING